ES2071699T3 - Ariloxifenilpropilaminas, su preparacion y empleo. - Google Patents

Ariloxifenilpropilaminas, su preparacion y empleo.

Info

Publication number
ES2071699T3
ES2071699T3 ES90109829T ES90109829T ES2071699T3 ES 2071699 T3 ES2071699 T3 ES 2071699T3 ES 90109829 T ES90109829 T ES 90109829T ES 90109829 T ES90109829 T ES 90109829T ES 2071699 T3 ES2071699 T3 ES 2071699T3
Authority
ES
Spain
Prior art keywords
alcoxide
halogen
alkyl
replaced
cicloalkil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90109829T
Other languages
English (en)
Inventor
Palle Jakobsen
Jorgen Drejer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2071699T3 publication Critical patent/ES2071699T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
    • C07C217/72—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE PRESENTAN NUEVOS ARILOXIFENILPROPILAMINOS QUE TIENEN LA FORMULA (I) EN /A QUE X ES H, CIANO, HALOGENO, HALOGENO ALQUIL, ALCOXIDO C1-6, ALQUIL CX1-C6, ALCANOIL C1-5, ALQUILENO C3-5, ARILOXI O ARALKOXIDO, Y R ES 3,4-METILENEDIOXI, ARIL O HETEROARIL QUE ESTAN OPCIONALMENTE SUSTITUIDOS CON UNO O MAS CIANO, HALOGENO , ALQUIL C1-C6, ALCOXI C1-6, ALKENIL C1-6, TRIFLUOROMETIL, ALKILENO C3-5, ARILOXI O ARALCOXI: Y R1 Y R2 INDEPENDIENTEMENTE SON ALKIL C1-10, CICLOALKIL C3-7, ALKENIL C2-10, CICLOALKIL C3-6, ALKIL C1-5, OPCIONALMENTE SUSTITUIDO CON ALCOXIDO C1-5 O CIANO; O R1 Y R2 PUEDEN FORMAR JUNTAS UN ANILLO CARBOCICLICO O UNA SAL DEL MISMO CON UN ACIDO FARMACEUTICAMENTE ACEPTABLE, CON LA PROMISION DE QUE R1 NO SEA CICLOALQUIL C3-7, ALKIL C1-10, O ALQUENIL QUE SEA RECTO, RAMIFICADO O CICLICO, NO SUSTITUIDO O SUSTITUIDO CON ALCOXIDO C1C4, RILOXIDO O CICLOAQUIL O CICLOALQUILALQUIL, DONDE X ES H Y R2 ES UN GRUPO METIL. LOS NUEVOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE LA EPILEPSIA, MIGRAÑA,ISQUEMIA, DAÑOS TRAUMATICOS Y ENFERMEDADES NEURODEGENERATIVAS.
ES90109829T 1989-05-26 1990-05-23 Ariloxifenilpropilaminas, su preparacion y empleo. Expired - Lifetime ES2071699T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK258389A DK258389D0 (da) 1989-05-26 1989-05-26 Aryloxyphenylpropylaminer, deres fremstilling og anvendelse

Publications (1)

Publication Number Publication Date
ES2071699T3 true ES2071699T3 (es) 1995-07-01

Family

ID=8113376

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90109829T Expired - Lifetime ES2071699T3 (es) 1989-05-26 1990-05-23 Ariloxifenilpropilaminas, su preparacion y empleo.

Country Status (16)

Country Link
US (2) US5145870A (es)
EP (1) EP0399504B1 (es)
JP (1) JPH0317046A (es)
AT (1) ATE122031T1 (es)
AU (1) AU641653B2 (es)
CA (1) CA2017468A1 (es)
DE (1) DE69019060T2 (es)
DK (2) DK258389D0 (es)
ES (1) ES2071699T3 (es)
FI (1) FI902629A7 (es)
IE (1) IE70070B1 (es)
IL (1) IL94452A (es)
NO (1) NO174342C (es)
NZ (1) NZ233809A (es)
PT (1) PT94167B (es)
ZA (1) ZA904072B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0576766A1 (en) * 1992-06-29 1994-01-05 Novo Nordisk A/S Propanolamine derivatives, their preparation and use
US6071970A (en) * 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6750244B2 (en) 1993-02-08 2004-06-15 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6211245B1 (en) 1993-02-08 2001-04-03 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6017965A (en) * 1993-02-08 2000-01-25 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US7087765B2 (en) 1995-06-07 2006-08-08 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
DE69434889D1 (de) 1994-02-08 2007-01-11 Nps Pharma Inc An einer neuen Stelle von Rezeptorabhängigen Kalziumkanälen wirkende Verbindungen zur Behandlung von neurologischen Erkrankungen
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
IT1304874B1 (it) * 1998-07-17 2001-04-05 Univ Firenze Amminoalcoli,amminochetoni e loro derivati,loro preparazione ed usocome farmaci per le patologie del sistema nervoso centrale (snc) e
GB0004153D0 (en) 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel use
GB0004151D0 (en) 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel use
GB0004152D0 (en) 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel compounds
SE0102640D0 (sv) 2001-07-31 2001-07-31 Astrazeneca Ab Novel compounds
SE0102639D0 (sv) * 2001-07-31 2001-07-31 Astrazeneca Ab Novel compounds
SE0102641D0 (sv) * 2001-07-31 2001-07-31 Astrazeneca Ab Novel compounds
US6846957B2 (en) * 2002-11-22 2005-01-25 Board Of Regents, The University Of Texas System Synthesis of 3-aminomethyl-1-propanol, a fluoxetine precursor
WO2005063707A1 (en) * 2003-12-26 2005-07-14 Natco Pharma Limited Enantiospecific process for the preparation of paroxetine intermediate
ITMI20061987A1 (it) * 2006-10-16 2008-04-17 Archimica Srl Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine.
WO2008081477A1 (en) * 2007-01-04 2008-07-10 Natco Pharma Limited 3-aryloxy 3-substituted propanamines
JP5246715B2 (ja) * 2009-01-27 2013-07-24 独立行政法人科学技術振興機構 蛋白質架橋阻害剤およびその用途
DE102009036164B4 (de) 2009-05-28 2011-06-09 Schott Ag Verfahren zum Biegen und thermischen Vorspannen von Strahlenschutzglas
WO2014046544A1 (en) * 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3095449A (en) * 1957-08-06 1963-06-25 Bayer Ag 1-(gamma-dimethylaminopropoxy)-2-alkoxy alkenylbenzenes
CH609331A5 (en) * 1974-01-10 1979-02-28 Lilly Co Eli Process for the preparation of 3-aryloxy-3-phenyl-propylamines
US4194009A (en) * 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
FR2432500A1 (fr) * 1978-02-24 1980-02-29 Roussel Uclaf Nouveaux derives de la benzene propanamine et leurs sels, procede de preparation et application a titre de medicaments
DE2940765A1 (de) * 1979-10-08 1981-04-23 Basf Ag, 6700 Ludwigshafen Substituierte alkylammoniumsalze, ihre herstellung, ihre verwendung zur regulierung des pflanzenwachstums und mittel dafuer
DE2950135A1 (de) * 1979-12-13 1981-06-19 Merck Patent Gmbh, 6100 Darmstadt Basischer aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
FI77018C (fi) * 1980-11-14 1989-01-10 Lilly Co Eli Analogifoerfarande foer framstaellning av antidepressivt aktiv (-)-enantiomer av n-metyl-n-/3-(2-metylfenoxi) -3-fenylpropyl/amin och dess farmaceutiskt godtagbara salt.
US4956388A (en) * 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
IL85988A (en) * 1987-04-09 1992-08-18 Lilly Co Eli 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them
DK630987D0 (da) * 1987-12-01 1987-12-01 Ferrosan As Aryloxyphenylpropylaminer, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
IL94452A (en) 1995-11-27
EP0399504B1 (en) 1995-05-03
FI902629A0 (fi) 1990-05-25
EP0399504A3 (en) 1992-02-12
ATE122031T1 (de) 1995-05-15
NO902338L (no) 1990-11-27
FI902629A7 (fi) 1990-11-27
NO174342C (no) 1994-04-20
AU5582190A (en) 1990-11-29
EP0399504A2 (en) 1990-11-28
IE70070B1 (en) 1996-10-30
IE901790L (en) 1990-11-26
NZ233809A (en) 1993-04-28
PT94167A (pt) 1991-01-08
DE69019060T2 (de) 1995-08-31
IL94452A0 (en) 1991-03-10
NO902338D0 (no) 1990-05-25
DK0399504T3 (da) 1995-09-04
DE69019060D1 (de) 1995-06-08
ZA904072B (en) 1991-03-27
PT94167B (pt) 1996-12-31
US5310756A (en) 1994-05-10
NO174342B (no) 1994-01-10
AU641653B2 (en) 1993-09-30
DK258389D0 (da) 1989-05-26
CA2017468A1 (en) 1990-11-26
JPH0317046A (ja) 1991-01-25
US5145870A (en) 1992-09-08

Similar Documents

Publication Publication Date Title
ES2071699T3 (es) Ariloxifenilpropilaminas, su preparacion y empleo.
DK0640592T3 (da) N-acylerede tricycliske azaheteroringe anvendelige som vasopressin-antagonister
ES2185827T3 (es) Metodo de preparacion de material biologico para implantacion.
ES2094721T3 (es) Analogos de la camptotecina solubles en agua.
ES2067466T3 (es) Dispersante.
AR002459A1 (es) Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
ES2061463T3 (es) Compuestos de piperidina y su preparacion y uso.
ES2051730T5 (es) Composiciones de espesamiento y soluciones acidas acuosas espesadas.
ID24219A (id) Turunan dibenzotiazotiazepina kristalin dan penggunaannya sebagai zat antipsikotik
AR016010A1 (es) UN COMPUESTO DERIVADO DE ACIDO SULFONHIDROXAMICO AROMATICO INHIBIDOR DE METALOPROTEASAS, COMPUESTO INTERMEDIARIO, PROCESO PARA FORMARLO, COMPOSICION FARMACEUTICA Y USO PARA EL TRATAMIENTO DE UN ANIMAL HUESPED MAMíFERO.
ATE39483T1 (de) Kondensierte pyrrolinon-derivate, und ihre herstellung.
ES2113081T3 (es) 1,4-benzotiazepinas utiles como agentes neurologicos.
ES2132882T3 (es) Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina 1.
AR037940A1 (es) Compuestos antivirales de piridoquinoxalina
ES2133295T3 (es) Peptidos ciclicos y su uso.
ES2163396T3 (es) Aminas biologicamente activas.
AR023914A1 (es) Caprolactamas sustituidas, un proceso para su preparacion, composiciones farmaceuticas que las contienen, y su uso para la preparacion de composicionesfarmaceuticas en el tratamiento de tumores
DE69330601D1 (de) Serotoninergische ergolin derivate
ES2104987T3 (es) Derivados de eteres milbemicina, su preparacion y su aplicacion terapeutica y agroquimica.
NO983531D0 (no) Dihydrobenzofuranforbindelser anvendelig som antiinflammatoriske midler
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
PE41896A1 (es) Antagonista del receptor de aminoacido excitativo
AR010650A1 (es) COMPUESTO DERIVADO DE CEFEm, COMPOSICION FARMACEUTICA QUE LO CONTIENE Y USO DEL MISMO
DK0660822T3 (da) Cykliske benzylamino-, benzylamido- og benzylimidoderivater som antipsykotiske midler
ES2063771T3 (es) Nuevos derivados de amida del acido 4-oxo-4h-pirido (1,2-a) pirimidin-3-carboxilicos, su preparacion y elaboracion de medicamentos que contienen estos compuestos, asi como la preparacion de los mismos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 399504

Country of ref document: ES